2024 HCPCS Code J7611
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
TAGS: final inhalation through administered concentrated
| Short Description | Albuterol non-comp con |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | July 01, 2009 |
| HCPCS Code Added Date | January 01, 2005 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J8565 - Gefitinib oral
- J8597 - Antiemetic drug oral nos
- J8600 - Melphalan oral 2 mg
- J8610 - Methotrexate oral 2.5 mg
- J8611 - Oral methotrexate (jylamvo)
- J8612 - Oral methotrexate (xatmep)
- J8650 - Nabilone oral
- J8655 - Oral netupitant, palonosetro
- J8670 - Rolapitant, oral, 1mg
- J8700 - Temozolomide
- J8705 - Topotecan oral
- J8999 - Oral prescription drug chemo
- J9000 - Doxorubicin hcl injection
- J9010 - Alemtuzumab injection
- J9015 - Aldesleukin injection
- J9017 - Arsenic trioxide injection
- J9019 - Erwinaze injection
- J9020 - Asparaginase, nos
- J9021 - Inj, aspara, rylaze, 0.1 mg
- J9022 - Inj, atezolizumab,10 mg